RxDoctor Payments Data

David Chiapaikeo, MD

Vascular Surgery · Columbus, INNPI 1174814644

Payments from drug & device makers

What this record shows

15 manufacturers reported payments, led by Medtronic at 58.3% of the total. Reporting peaked in 2019 at $1,443 and has fallen 93.0% since, to $101 in 2025. That places this record below the midpoint for vascular surgery clinicians in IN, where the typical reported total is $4,328.

$2,103in general payments, 2019–2025

Across 30 payments — averaging $70.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Abbott$184
  • Silk Road Medical, Inc.$178
  • Endologix LLC$118
  • Getinge USA Sales, LLC$91
  • Inari Medical, Inc.$68
  • plus $237 from 9 others

What the payments were for

  • Grants$1,00048%
  • Food & beverage$1,10352%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,103 in reported general payments places this provider in the 30th percentile of 71 vascular surgery providers in Indiana.

See all vascular surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$88,363
Medicare patients
295
Services billed
577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate30$161
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$129

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Columbus

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →